Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$31.20 +0.22 (+0.71%)
Closing price 04/30/2025 03:58 PM Eastern
Extended Trading
$32.52 +1.32 (+4.23%)
As of 09:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAX vs. BDX, EW, IDXX, RMD, DXCM, STE, PODD, HOLX, GMED, and MASI

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation, dividends and community ranking.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$10.64B1.50-$649M-$1.28-24.38
Becton, Dickinson and Company$20.64B2.88$1.71B$6.0234.37

Becton, Dickinson and Company has a net margin of 8.47% compared to Baxter International's net margin of -5.05%. Baxter International's return on equity of 16.67% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International-5.05% 16.67% 4.93%
Becton, Dickinson and Company 8.47%15.74%7.29%

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Baxter International received 133 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.69% of users gave Baxter International an outperform vote while only 62.46% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Baxter InternationalOutperform Votes
737
65.69%
Underperform Votes
385
34.31%
Becton, Dickinson and CompanyOutperform Votes
604
62.46%
Underperform Votes
363
37.54%

Baxter International has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500.

In the previous week, Becton, Dickinson and Company had 25 more articles in the media than Baxter International. MarketBeat recorded 34 mentions for Becton, Dickinson and Company and 9 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.33 beat Baxter International's score of 0.57 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
22 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Baxter International pays an annual dividend of $0.68 per share and has a dividend yield of 2.2%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.0%. Baxter International pays out -53.1% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Baxter International is clearly the better dividend stock, given its higher yield and lower payout ratio.

Baxter International presently has a consensus price target of $38.56, suggesting a potential upside of 23.58%. Becton, Dickinson and Company has a consensus price target of $272.86, suggesting a potential upside of 31.89%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.40
Becton, Dickinson and Company
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Becton, Dickinson and Company beats Baxter International on 14 of the 21 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$16.00B$4.39B$5.56B$18.97B
Dividend Yield2.24%39.94%5.11%4.02%
P/E Ratio-24.3830.6722.5132.71
Price / Sales1.5054.91395.6827.84
Price / Cash6.4551.0838.1817.53
Price / Book1.876.116.774.47
Net Income-$649M$68.15M$3.22B$1.02B
7 Day Performance2.63%-0.12%1.45%0.50%
1 Month Performance-8.32%-2.24%3.97%-2.83%
1 Year Performance-22.66%24.15%16.14%4.36%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.2929 of 5 stars
$31.20
+0.7%
$38.56
+23.6%
-22.7%$16.00B$10.64B-24.3860,000
BDX
Becton, Dickinson and Company
4.903 of 5 stars
$205.10
+0.0%
$272.86
+33.0%
-11.8%$58.89B$20.64B34.0777,000Dividend Announcement
Positive News
EW
Edwards Lifesciences
4.6057 of 5 stars
$75.55
-0.6%
$79.45
+5.2%
-10.8%$44.41B$5.25B10.8417,300Short Interest ↓
Analyst Revision
Positive News
IDXX
IDEXX Laboratories
3.9513 of 5 stars
$434.49
-0.7%
$523.75
+20.5%
-12.2%$35.21B$3.90B40.7210,800Positive News
RMD
ResMed
3.917 of 5 stars
$234.06
-0.8%
$258.83
+10.6%
+10.5%$34.38B$5.02B27.638,160Dividend Announcement
DXCM
DexCom
4.9391 of 5 stars
$71.21
-0.6%
$99.00
+39.0%
-44.0%$27.92B$4.03B49.797,600Positive News
STE
STERIS
4.4967 of 5 stars
$225.26
+0.1%
$258.75
+14.9%
+9.8%$22.13B$5.40B47.8316,000Upcoming Earnings
Short Interest ↑
Positive News
PODD
Insulet
4.481 of 5 stars
$259.86
-0.3%
$292.06
+12.4%
+46.7%$18.25B$2.07B44.882,600Upcoming Earnings
Analyst Forecast
News Coverage
HOLX
Hologic
4.8718 of 5 stars
$58.09
+0.1%
$84.62
+45.7%
-23.2%$13.03B$4.04B18.326,940Positive News
GMED
Globus Medical
4.8067 of 5 stars
$72.58
-0.3%
$96.91
+33.5%
+44.2%$9.98B$2.52B96.772,600Upcoming Earnings
Short Interest ↑
MASI
Masimo
3.7911 of 5 stars
$163.99
+0.2%
$194.80
+18.8%
+19.8%$8.86B$2.09B113.106,200Upcoming Earnings
Positive News

Related Companies and Tools


This page (NYSE:BAX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners